Hide metadata

dc.date.accessioned2022-08-02T16:44:16Z
dc.date.available2022-08-02T16:44:16Z
dc.date.created2022-06-30T15:35:58Z
dc.date.issued2022
dc.identifier.citationClarsen, Benjamin Matthew Nylenna, Magne Klitkou, Søren Toksvig Vollset, Stein Emil Baravelli, Carl Michael Bølling, Anette Kocbach Aasvang, Gunn Marit Sulo, Gerhard Naghavi, Mohsen Pasovic, Maja Asaduzzaman, Muhammad Bjørge, Tone Eggen, Anne Elise Eikemo, Terje Andreas Ellingsen, Christian Lycke Haaland, Øystein Ariansen Hailu, Alemayehu Hassan, Shoaib Hay, Simon I. Juliusson, Pétur Benedikt Kisa, Adnan Kisa, Sezer Månsson, Johan Yitayew, Teferi Mekonnen Murray, Christopher J L Norheim, Ole Frithjof Ottersen, Trygve Sagoe, Dominic Sripada, Kam Winkler, Andrea Sylvia Knudsen, Ann Kristin Skrindo . Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019. The Lancet Public Health. 2022, 7, 593-605
dc.identifier.urihttp://hdl.handle.net/10852/94710
dc.description.abstractBackground Geographical differences in health outcomes are reported in many countries. Norway has led an active policy aiming for regional balance since the 1970s. Using data from the Global Burden of Disease Study (GBD) 2019, we examined regional differences in development and current state of health across Norwegian counties. Methods Data for life expectancy, healthy life expectancy (HALE), years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) in Norway and its 11 counties from 1990 to 2019 were extracted from GBD 2019. County-specific contributors to changes in life expectancy were compared. Inequality in disease burden was examined by use of the Gini coefficient. Findings Life expectancy and HALE improved in all Norwegian counties from 1990 to 2019. Improvements in life expectancy and HALE were greatest in the two counties with the lowest values in 1990: Oslo, in which life expectancy and HALE increased from 71·9 years (95% uncertainty interval 71·4–72·4) and 63·0 years (60·5–65·4) in 1990 to 81·3 years (80·0–82·7) and 70·6 years (67·4–73·6) in 2019, respectively; and Troms og Finnmark, in which life expectancy and HALE increased from 71·9 years (71·5–72·4) and 63·5 years (60·9–65·6) in 1990 to 80·3 years (79·4–81·2) and 70·0 years (66·8–72·2) in 2019, respectively. Increased life expectancy was mainly due to reductions in cardiovascular disease, neoplasms, and respiratory infections. No significant differences between the national YLD or DALY rates and the corresponding age-standardised rates were reported in any of the counties in 2019; however, Troms og Finnmark had a higher age-standardised YLL rate than the national rate (8394 per 100 000 [95% UI 7801–8944] vs 7536 per 100 000 [7391–7691]). Low inequality between counties was shown for life expectancy, HALE, all level-1 causes of DALYs, and exposure to level-1 risk factors. Interpretation Over the past 30 years, Norway has reduced inequality in disease burden between counties. However, inequalities still exist at a within-county level and along other sociodemographic gradients. Because of insufficient Norwegian primary data, there remains substantial uncertainty associated with regional estimates for non-fatal disease burden and exposure to risk factors.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleChanges in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019
dc.title.alternativeENEngelskEnglishChanges in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019
dc.typeJournal article
dc.creator.authorClarsen, Benjamin Matthew
dc.creator.authorNylenna, Magne
dc.creator.authorKlitkou, Søren Toksvig
dc.creator.authorVollset, Stein Emil
dc.creator.authorBaravelli, Carl Michael
dc.creator.authorBølling, Anette Kocbach
dc.creator.authorAasvang, Gunn Marit
dc.creator.authorSulo, Gerhard
dc.creator.authorNaghavi, Mohsen
dc.creator.authorPasovic, Maja
dc.creator.authorAsaduzzaman, Muhammad
dc.creator.authorBjørge, Tone
dc.creator.authorEggen, Anne Elise
dc.creator.authorEikemo, Terje Andreas
dc.creator.authorEllingsen, Christian Lycke
dc.creator.authorHaaland, Øystein Ariansen
dc.creator.authorHailu, Alemayehu
dc.creator.authorHassan, Shoaib
dc.creator.authorHay, Simon I.
dc.creator.authorJuliusson, Pétur Benedikt
dc.creator.authorKisa, Adnan
dc.creator.authorKisa, Sezer
dc.creator.authorMånsson, Johan
dc.creator.authorYitayew, Teferi Mekonnen
dc.creator.authorMurray, Christopher J L
dc.creator.authorNorheim, Ole Frithjof
dc.creator.authorOttersen, Trygve
dc.creator.authorSagoe, Dominic
dc.creator.authorSripada, Kam
dc.creator.authorWinkler, Andrea Sylvia
dc.creator.authorKnudsen, Ann Kristin Skrindo
cristin.unitcode185,52,14,0
cristin.unitnameAvd. for samfunnsmedisin og global helse
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2036417
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=The Lancet Public Health&rft.volume=7&rft.spage=593&rft.date=2022
dc.identifier.jtitleThe Lancet Public Health
dc.identifier.volume7
dc.identifier.issue7
dc.identifier.startpagee593
dc.identifier.endpagee605
dc.identifier.doihttps://doi.org/10.1016/S2468-2667(22)00092-5
dc.identifier.urnURN:NBN:no-97246
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2468-2667
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/94710/1/1-s2.0-S2468266722000925-main.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International